Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Identifying common mistakes in retirement planning can save you from future pitfalls. Learn what to avoid for a secure retirement.
14,327 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Balancing personal and business finances is essential for freelancers and small business owners. This guide explains ...
Insider moves can be deciphered like a language. This article uses credo's sold 31,290 shares as a practical case stu...
The crowd may be selling Intuitive Surgical too quickly. A Goldman Sachs perspective argues the long-term setup remai...
A seasoned market watcher outlines a bold bull case for Bitcoin and Ethereum, suggesting cryptocurrencies poised soar...
Metallus faces a dynamic metals market in 2025. This guide breaks down expected MTUS 2025 earnings, the drivers behin...
The world economic forum head Børge Brende resigned Thursday amid scrutiny over ties to Jeffrey Epstein. An independe...
Investors are watching a potential shift at HubSpot as AI features expand across its platform. This guide breaks down...
Netflix moves to acquire Ben Affleck's AI startup for up to $600 million, signaling a rapid shift from internal tool-...
Gas prices have been volatile, but a single factor sets the pace at the pump. This reader-friendly guide explains the...
Investors are watching novavax (nvax) 2025 earnings closely as the company pivots its vaccine portfolio. This article...
Canadian travel to the United States is declining beyond leisure trips, with business travel and investor visits fall...